PDCD1 and cancer: Generally, the interaction of PD-1 with PD-L-1 occurs in trans and produces inhibitory signals for attenuating T-cell responses, especially when these receptors are expressed on the T-cells of antigen presenting cells (APCs) or cancer cells.